½ÃÀ庸°í¼­
»óǰÄÚµå
1773770

Àü±â»ý¸® ÀýÁ¦ ½ÃÀå : ¼¼°è »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ, ¿¹Ãø(2025-2032³â)

Electrophysiology Ablation Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Persistence Market Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 220 Pages | ¹è¼Û¾È³» : 2-5ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

Persistence Market Research´Â ÃÖ±Ù ¼¼°è Àü±â»ý¸® ÀýÁ¦ ½ÃÀå¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ ºÐ¼®À» ¹ßÇ¥Çß½À´Ï´Ù. ÀÌ º¸°í¼­´Â ½ÃÀå ÃËÁø¿äÀÎ, µ¿Çâ, ±âȸ ¹× °úÁ¦¿Í °°Àº Áß¿äÇÑ ½ÃÀå ¿ªÇÐÀ» öÀúÈ÷ Æò°¡ÇÏ°í ½ÃÀå ±¸Á¶¿¡ ´ëÇÑ ½ÉÃþÀûÀÎ ÀλçÀÌÆ®¸¦ Á¦°øÇÕ´Ï´Ù. ÀÌ º¸°í¼­´Â ¼¼°è Àü±â»ý¸® ÀýÁ¦ ½ÃÀåÀÇ ¿¹Ãø ¼ºÀå ±ËÀû(2025-2032³â)À» °³°ýÇÏ´Â µ¶Á¡ÀûÀÎ µ¥ÀÌÅÍ¿Í Åë°è¸¦ Á¦°øÇÕ´Ï´Ù.

ÁÖ¿ä ÀλçÀÌÆ®

  • Àü±â»ý¸® ÀýÁ¦ ½ÃÀå ±Ô¸ð(2025³â) : 38¾ï 4,710¸¸ ´Þ·¯
  • ½ÃÀå ±Ô¸ð ¿¹Ãø(±Ý¾× ±âÁØ, 2032³â) : 69¾ï 4,280¸¸ ´Þ·¯
  • ¼¼°è ½ÃÀå ¼ºÀå·ü(CAGR, 2025-2032³â) : 8.8%

Àü±â»ý¸® ÀýÁ¦ ½ÃÀå - ºÐ¼® ¹üÀ§

Àü±â»ý¸® ÀýÁ¦ ½ÃÀåÀº ½ÉÀåÀÇ ºñÁ¤»óÀûÀÎ Àü±âÀû °æ·Î¸¦ Ç¥ÀûÀ¸·Î ÁßÈ­ÇÏ¿© ºñÁ¤»óÀûÀÎ ½ÉÀå ¸®µëÀ» Ä¡·áÇÏ´Â µ¥ »ç¿ëµÇ´Â ÀÇ·á ½Ã¼ú ¹× ±â±â·Î ±¸¼ºµË´Ï´Ù. ÀÌ ½Ã¼úÀº ½É¹æ¼¼µ¿, ½É¹æÁ¶µ¿, ½É½Çºó¸Æ°ú °°Àº ÁúȯÀÇ °ü¸®¿¡ ³Î¸® »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. ½ÉÀå ºÎÁ¤¸ÆÀÇ À¯º´·ü Áõ°¡¿Í ÀýÁ¦¿ë Ä«Å×ÅÍ ¹× ¿µ»ó Áø´Ü ½Ã½ºÅÛÀÇ ±â¼ú Çõ½ÅÀÌ Àü ¼¼°èÀûÀ¸·Î Àü±â»ý¸® ÀýÁ¦¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÁÖµµÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÃÖ¼Òħ½ÀÀûÀÌ°í ³ôÀº ¼º°ø·ü·Î ÀÎÇØ ÀÌ ½ÃÀåÀÇ Ã¤ÅÃÀÌ È®´ëµÇ°í ÀÖ½À´Ï´Ù.

½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ:

½ÉÇ÷°ü°è Áúȯ, ƯÈ÷ ½É¹æ¼¼µ¿ ¹× ±âŸ ºÎÁ¤¸ÆÀÇ Áõ°¡´Â Àü±â»ý¸® ÀýÁ¦ ½ÃÀåÀ» À̲ô´Â ÁÖ¿ä ¿äÀÎÀÔ´Ï´Ù. Á¶±â Áø´Ü ¹× Ä¡·á¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö°í ½ÉÀå Áúȯ¿¡ Ãë¾àÇÑ ³ë·É Àα¸ÀÇ Áõ°¡°¡ ½ÃÀå È®´ë¿¡ Å©°Ô ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Á¢ÃË·Â °¨Áö Ä«Å×ÅÍ, ·Îº¿ ³»ºñ°ÔÀÌ¼Ç ½Ã½ºÅÛ µî ÀýÁ¦ ±â¼úÀÇ Áö¼ÓÀûÀÎ ¹ßÀüÀ¸·Î ½Ã¼úÀÇ Á¤È®¼º°ú Ä¡·á °á°ú°¡ Çâ»óµÇ°í ÀÖ½À´Ï´Ù. ¼±Áø±¹°ú ½ÅÈï±¹ ¸ðµÎ¿¡¼­ Á¤ºÎÀÇ Áö¿øÃ¥°ú ÀÇ·áºñ ÁöÃâµµ ½ÃÀå °³Ã´À» °­È­Çϰí ÀÖ½À´Ï´Ù.

½ÃÀå ¾ïÁ¦¿äÀÎ:

¾çÈ£ÇÑ ¼ºÀå ¿©°Ç¿¡µµ ºÒ±¸Çϰí Àü±â»ý¸® ÀýÁ¦ ½ÃÀåÀº ¸î °¡Áö Á¦¾à¿¡ Á÷¸éÇØ ÀÖ½À´Ï´Ù. ƯÈ÷ Àú¼Òµæ Áö¿ª¿¡¼­´Â ³ôÀº ½Ã¼ú ºñ¿ë°ú ÀϺΠ±¹°¡ÀÇ Á¦ÇÑÀûÀÎ »óȯ Á¤Ã¥À¸·Î ÀÎÇØ ȯÀÚÀÇ Á¢±Ù¼ºÀÌ Á¦ÇÑµÉ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÀýÁ¦¼úÀÇ º¹À⼺À¸·Î ÀÎÇØ ¼÷·ÃµÈ Àü±â»ý¸®ÇÐ Àü¹®°¡°¡ ÇÊ¿äÇϸç, ¼÷·ÃµÈ Àü¹®°¡°¡ ºÎÁ·ÇÏ¿© ½Ã¼ú µµÀÔ¿¡ °É¸²µ¹ÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù. ½ÉÀå õ°øÀ̳ª ³úÁ¹Áß°ú °°Àº ÇÕº´Áõ¿¡ ´ëÇÑ ¿ì·Áµµ µå¹°Áö¸¸ ¾ïÁ¦¿äÀÎÀ¸·Î ÀÛ¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ½Å±â¼ú ½ÂÀÎ ÀýÂ÷¿¡ ½Ã°£ÀÌ ¿À·¡ °É¸®±â ¶§¹®¿¡ Çõ½ÅÀûÀÎ ±â±âÀÇ ½ÃÀå ÁøÀÔÀÌ Áö¿¬µÉ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå ±âȸ:

ÀΰøÁö´É°ú 3D ¸ÅÇÎ ±â¼úÀÇ ÅëÇÕÀº Àü±â»ý¸® ÀýÁ¦ÀÇ ½Ã¼ú °èȹ°ú ½Ç½Ã°£ ¸ð´ÏÅ͸µÀ» °³¼±ÇÒ ¼ö ÀÖ´Â Å« ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù. Àεµ, Áß±¹, ºê¶óÁú°ú °°Àº ½ÅÈï±¹ÀÇ ÀÇ·á ÀÎÇÁ¶óÀÇ ±Þ¼ÓÇÑ È®ÀåÀ¸·Î ÀÎÇØ ¹æ´ëÇÑ ½ÃÀå °¡´É¼ºÀÌ ¿­¸®°í ÀÖ½À´Ï´Ù. ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ ¹× ½ÉÀå Àü¹® ¼¾ÅÍ¿¡¼­ÀÇ ¿Ü·¡ Àü±â»ý¸®ÇÐÀû ½Ã¼úÀÇ Áõ°¡ Ãß¼¼µµ »õ·Î¿î ¼ºÀå °¡´É¼ºÀ» âÃâÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÀÓ»ó½ÃÇè ¹× ±â±â °³¹ßÀ» À§ÇÑ ÀÇ·á ±â¼ú ±â¾÷°ú º´¿øÀÇ Çù·ÂÀ¸·Î º¸´Ù È¿À²ÀûÀÌ°í ¾ÈÀüÇÑ ÀýÁ¦ ±â¼ú°ú ȸº¹ ½Ã°£ ´ÜÃàÀ» À§ÇÑ ±æÀÌ ¿­¸®°í ÀÖ½À´Ï´Ù.

º» º¸°í¼­¿¡¼­ ´äº¯ÇÏ´Â ÁÖ¿ä Áú¹®

  • ¼¼°è Àü±â»ý¸® ÀýÁ¦ ½ÃÀåÀÇ ¼ºÀåÀ» ÃËÁøÇÏ´Â ÁÖ¿ä ¿äÀÎÀº ¹«¾ùÀΰ¡?
  • ÀýÁ¦ ±â¼ú¿¡ ´ëÇÑ ¼ö¿ä°¡ °¡Àå ³ôÀº Áö¿ª°ú ÀÀ¿ë ºÐ¾ß´Â?
  • ÀýÁ¦ ±â¼úÀÇ Çõ½ÅÀº Ä¡·á ¼º°ú¿Í ȯÀÚ ¾ÈÀü¿¡ ¾î¶² ¿µÇâÀ» ¹ÌÄ¡°í Àִ°¡?
  • Àü±â»ý¸® ÀýÁ¦ ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷°ú Àü·«Àû ¿ì¼±¼øÀ§´Â?
  • ¼¼°è Àü±â»ý¸® ÀýÁ¦ ½ÃÀåÀÇ »õ·Î¿î Æ®·»µå¿Í Àå±â Àü¸ÁÀº?

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå °³¿ä

  • ½ÃÀå ¹üÀ§¿Í Á¤ÀÇ
  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ±âȸ
    • °úÁ¦
    • ÁÖ¿ä µ¿Çâ
  • COVID-19ÀÇ ¿µÇ⠺м®
  • ¿¹Ãø¿äÀÎ : °ü·Ã¼º°ú ¿µÇâ

Á¦3Àå ºÎ°¡°¡Ä¡ ºÐ¼®

  • ¹ë·ùüÀÎ ºÐ¼®
  • Á¦Ç° ä¿ë/»ç¿ë »óȲ ºÐ¼®
  • ÁÖ¿ä ½ÃÀå ±â¾÷
  • ÁÖ¿ä ±â¾÷¿¡ ÀÇÇÑ ÁÖ¿ä ÇÁ·Î¸ð¼Ç Àü·«
  • ±ÔÁ¦ »óȲ
  • PESTLE ºÐ¼®
  • Porter's Five Forces ºÐ¼®

Á¦4Àå ¼¼°èÀÇ Àü±â»ý¸® ÀýÁ¦ ½ÃÀå Àü¸Á

  • ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
    • ½ÃÀå ±Ô¸ð¿Í Àü³âºñ ¼ºÀå·ü(±Ý¾× ±âÁØ)
    • Àý´ëÀû ¼öÀÍ ±âȸ
  • ½ÃÀå ±Ô¸ð ºÐ¼®°ú ¿¹Ãø(±Ý¾× ±âÁØ)
    • °ú°Å ½ÃÀå ±Ô¸ð ºÐ¼®(±Ý¾× ±âÁØ, 2019-2024³â)
    • ÇöÀç ½ÃÀå ±Ô¸ð ºÐ¼®°ú ¿¹Ãø(±Ý¾× ±âÁØ, 2025-2032³â)
  • ¼¼°èÀÇ Àü±â»ý¸® ÀýÁ¦ ½ÃÀå Àü¸Á : Á¦Ç°º°
    • ¼Ò°³/ÁÖ¿ä ºÐ¼® °á°ú
    • °ú°Å ½ÃÀå ±Ô¸ð ºÐ¼® : Á¦Ç°º°(±Ý¾× ±âÁØ, 2019-2024³â)
    • ÇöÀç ½ÃÀå ±Ô¸ð ºÐ¼® : Á¦Ç°º°(±Ý¾× ±âÁØ, 2025-2032³â)
      • Áø´Ü Ä«Å×ÅÍ
      • ÀýÁ¦ Ä«Å×ÅÍ
      • ¾×¼¼½º µð¹ÙÀ̽º
    • ½ÃÀå ¸Å·Â ºÐ¼® : Á¦Ç°º°
  • ¼¼°èÀÇ Àü±â»ý¸® ÀýÁ¦ ½ÃÀå Àü¸Á : ¿ëµµº°
    • ¼Ò°³/ÁÖ¿ä ºÐ¼® °á°ú
    • °ú°Å ½ÃÀå ±Ô¸ð ºÐ¼® : ¿ëµµº°(±Ý¾× ±âÁØ, 2019-2024³â)
    • ÇöÀç ½ÃÀå ±Ô¸ð ºÐ¼® : ¿ëµµº°(±Ý¾× ±âÁØ, 2025-2032³â)
      • »ó½É½Ç¼ººó¸Æ(SVT) ÀýÁ¦
      • ½É½Çºó¸Æ(VT/VPC)
      • ½É¹æ¼¼µ¿(AF)
      • ½É¹æÁ¶µ¿
      • ±âŸ
    • ½ÃÀå ¸Å·Â ºÐ¼® : ¿ëµµº°
  • ¼¼°èÀÇ Àü±â»ý¸® ÀýÁ¦ ½ÃÀå Àü¸Á : ÃÖÁ¾»ç¿ëÀÚº°
    • ¼Ò°³/ÁÖ¿ä ºÐ¼® °á°ú
    • °ú°Å ½ÃÀå ±Ô¸ð ºÐ¼® : ÃÖÁ¾»ç¿ëÀÚº°(±Ý¾× ±âÁØ, 2019-2024³â)
    • ÇöÀç ½ÃÀå ±Ô¸ð ºÐ¼® : ÃÖÁ¾»ç¿ëÀÚº°(±Ý¾× ±âÁØ, 2025-2032³â)
      • º´¿ø
      • ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ
      • Àü¹® ½ÉÀå ¼¾ÅÍ
      • Ŭ¸®´Ð
    • ½ÃÀå ¸Å·Â ºÐ¼® : ÃÖÁ¾»ç¿ëÀÚº°

Á¦5Àå ¼¼°èÀÇ Àü±â»ý¸® ÀýÁ¦ ½ÃÀå Àü¸Á : Áö¿ªº°

  • ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
  • °ú°Å ½ÃÀå ±Ô¸ð ºÐ¼® : Áö¿ªº°(±Ý¾× ±âÁØ, 2019-2024³â)
  • ÇöÀç ½ÃÀå ±Ô¸ð ¿¹Ãø : Áö¿ªº°(±Ý¾× ±âÁØ, 2025-2032³â)
    • ºÏ¹Ì
    • À¯·´
    • µ¿¾Æ½Ã¾Æ
    • ³²¾Æ½Ã¾Æ ¹× ¿À¼¼¾Æ´Ï¾Æ
    • ¶óƾ¾Æ¸Þ¸®Ä«
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
  • ½ÃÀå ¸Å·Â ºÐ¼® : Áö¿ªº°

Á¦6Àå ºÏ¹ÌÀÇ Àü±â»ý¸® ÀýÁ¦ ½ÃÀå Àü¸Á

Á¦7Àå À¯·´ Àü±â»ý¸®ÇÐ ÀýÁ¦ ½ÃÀå Àü¸Á

Á¦8Àå µ¿¾Æ½Ã¾ÆÀÇ Àü±â»ý¸® ÀýÁ¦ ½ÃÀå Àü¸Á

Á¦9Àå ³²¾Æ½Ã¾Æ ¹× ¿À¼¼¾Æ´Ï¾ÆÀÇ Àü±â»ý¸® ÀýÁ¦ ½ÃÀå Àü¸Á

Á¦10Àå ¶óÆ¾¾Æ¸Þ¸®Ä«ÀÇ Àü±â»ý¸® ÀýÁ¦ ½ÃÀå Àü¸Á

Á¦11Àå Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ Àü±â»ý¸® ÀýÁ¦ ½ÃÀå Àü¸Á

Á¦12Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®(2025³â)
  • ½ÃÀå ±¸Á¶
    • °æÀï °­µµ ¸Ê : ½ÃÀ庰
    • °æÀï ´ë½Ãº¸µå
  • ±â¾÷ °³¿ä(»ó¼¼ : °³¿ä, À繫, Àü·«, ÃÖ±Ù µ¿Çâ)
    • Biosense Webster
    • Abbott Laboratories
    • MEDTRONIC PLC
    • Boston Scientific Corporation
    • CathRx Ltd
    • Biotronik SE & Co. KG.
    • Japan Lifeline Co
    • ATRICURE, INC.
    • Auris Health
    • Biomerics.
    • Others

Á¦13Àå ºÎ·Ï

  • ºÐ¼® ¹æ¹ý
  • ºÐ¼® °¡Á¤
  • µÎ¹®ÀÚ¾î¿Í ¾à¾î
ksm

Persistence Market Research has recently released a comprehensive report on the global Electrophysiology Ablation Market, providing an in-depth analysis of key market dynamics, including driving forces, emerging trends, opportunities, and challenges. This report offers a detailed understanding of the market landscape, helping stakeholders make well-informed decisions.

Key Insights:

  • Electrophysiology Ablation Market Size (2025E): US$ 3,847.1 Mn
  • Projected Market Value (2032F): US$ 6,942.8 Mn
  • Global Market Growth Rate (CAGR 2025 to 2032): 8.8%

Electrophysiology Ablation Market - Report Scope:

The electrophysiology ablation market comprises medical procedures and devices used to treat abnormal heart rhythms by targeting and neutralizing faulty electrical pathways in the heart. The procedure is widely used in managing conditions such as atrial fibrillation, atrial flutter, and ventricular tachycardia. Increasing prevalence of cardiac arrhythmias, coupled with technological innovations in ablation catheters and imaging systems, are driving the demand for electrophysiology ablation worldwide. The market is also witnessing growing adoption due to its minimally invasive nature and higher success rates.

Market Growth Drivers:

The growing burden of cardiovascular diseases, particularly atrial fibrillation and other arrhythmias, is a major factor propelling the electrophysiology ablation market. Increased awareness of early diagnosis and treatment, along with the rising geriatric population prone to heart conditions, is contributing significantly to market expansion. Moreover, continuous advancements in ablation technologies, such as contact force-sensing catheters and robotic navigation systems, are enhancing procedural accuracy and outcomes. Supportive government initiatives and healthcare spending in both developed and developing nations are also strengthening market growth.

Market Restraints:

Despite favorable growth conditions, the electrophysiology ablation market faces several constraints. High procedural costs and limited reimbursement policies in some countries may restrict patient access, especially in low-income regions. Additionally, the complexity of ablation procedures requires skilled electrophysiologists, and a shortage of trained professionals can hinder procedural adoption. Concerns related to complications such as cardiac perforation or stroke, though rare, may also act as deterrents. Furthermore, long regulatory approval processes for new technologies can delay market entry for innovative devices.

Market Opportunities:

Significant opportunities lie in the integration of artificial intelligence and 3D mapping technologies to improve procedure planning and real-time monitoring in electrophysiology ablation. Rapid expansion of healthcare infrastructure in emerging economies like India, China, and Brazil opens up vast market potential. The growing trend of outpatient electrophysiology procedures in ambulatory surgical centers and specialty cardiac centers also creates new growth avenues. Furthermore, collaborations between medtech firms and hospitals for clinical trials and device development are paving the way for more efficient, safer ablation techniques with shorter recovery times.

Key Questions Answered in the Report:

  • What are the primary factors driving the global electrophysiology ablation market's growth?
  • Which regions and application areas are witnessing the highest demand for ablation procedures?
  • How are innovations in ablation technology influencing treatment outcomes and patient safety?
  • Who are the leading players in the electrophysiology ablation market and what are their strategic priorities?
  • What are the emerging trends and long-term forecasts for the global electrophysiology ablation market?

Competitive Intelligence and Business Strategy:

Leading companies in the global electrophysiology ablation market, such as Biosense Webster, Abbott Laboratories, and Boston Scientific Corporation, are focusing heavily on R&D and product innovation to gain a competitive edge. These firms are developing advanced ablation systems with real-time imaging, improved energy delivery, and enhanced navigation capabilities. Strategic partnerships with hospitals, acquisitions, and global expansion efforts are helping key players consolidate their market position. Emphasis is also placed on physician training and education programs to promote technology adoption in emerging regions.

Companies Covered in This Report:

  • Biosense Webster
  • Abbott Laboratories
  • MEDTRONIC PLC
  • Boston Scientific Corporation
  • CathRx Ltd
  • Biotronik SE & Co. KG.
  • Japan Lifeline Co
  • ATRICURE, INC.
  • Auris Health
  • Biomerics
  • Others

Market Segmentation

By Product Type:

  • Diagnostic Catheter
  • Ablation Catheter
  • Access Device

By Application:

  • Supraventricular Tachycardia (SVT) Ablation
  • Ventricular Tachycardia (VT/VPC)
  • Atrial Fibrillation (AF)
  • Atrial Flutter
  • Others

By End-User:

  • Hospital
  • Ambulatory Surgical Centre
  • Specialty Cardiac Centers
  • Clinic

By Region:

  • North America
  • Europe
  • East Asia
  • South Asia and Oceania
  • Latin America
  • Middle East and Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Electrophysiology Ablation Market Snapshot, 2025 and 2032
  • 1.2. Market Opportunity Assessment, 2025-2032, US$ Mn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Challenges
    • 2.2.5. Key Trends
  • 2.3. COVID-19 Impact Analysis
  • 2.4. Forecast Factors - Relevance and Impact

3. Value Added Insights

  • 3.1. Value Chain Analysis
  • 3.2. Product Adoption / Usage Analysis
  • 3.3. Key Market Players
  • 3.4. Key Promotional Strategies, By Key Players
  • 3.5. Regulatory Landscape
  • 3.6. PESTLE Analysis
  • 3.7. Porter's Five Force Analysis

4. Global Electrophysiology Ablation Market Outlook

  • 4.1. Key Highlights
    • 4.1.1. Market Size (US$ Mn) and Y-o-Y Growth
    • 4.1.2. Absolute $ Opportunity
  • 4.2. Market Size (US$ Mn) Analysis and Forecast
    • 4.2.1. Historical Market Size (US$ Mn) Analysis, 2019-2024
    • 4.2.2. Current Market Size (US$ Mn) Analysis and Forecast, 2025-2032
  • 4.3. Global Electrophysiology Ablation Market Outlook: Product
    • 4.3.1. Historical Market Size (US$ Mn) Analysis, By Product, 2019-2024
    • 4.3.2. Current Market Size (US$ Mn) Analysis, By Product, 2025-2032
      • 4.3.2.1. Diagnostic Catheter
      • 4.3.2.2. Ablation Catheter
      • 4.3.2.3. Access Device
    • 4.3.3. Market Attractiveness Analysis: Product
  • 4.4. Global Electrophysiology Ablation Market Outlook: Application
    • 4.4.1. Historical Market Size (US$ Mn) Analysis, By Application, 2019-2024
    • 4.4.2. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
      • 4.4.2.1. Supraventricular tachycardia (SVT) ablation
      • 4.4.2.2. Ventricular tachycardia (VT/VPC)
      • 4.4.2.3. Atrial fibrillation (AF)
      • 4.4.2.4. Atrial flutter
      • 4.4.2.5. Others
    • 4.4.3. Market Attractiveness Analysis: Application
  • 4.5. Global Electrophysiology Ablation Market Outlook: End-User
    • 4.5.1. Historical Market Size (US$ Mn) Analysis, By End-User, 2019-2024
    • 4.5.2. Current Market Size (US$ Mn) Analysis and Forecast, By End-User, 2025-2032
      • 4.5.2.1. Hospital
      • 4.5.2.2. Ambulatory Surgical Centre
      • 4.5.2.3. Specialty Cardiac Centers
      • 4.5.2.4. Clinic
    • 4.5.3. Market Attractiveness Analysis: End-User

5. Global Electrophysiology Ablation Market Outlook: Region

  • 5.1. Historical Market Size (US$ Mn) Analysis, By Region, 2019-2024
  • 5.2. Current Market Size (US$ Mn) Analysis, by Region, 2025-2032
    • 5.2.1. North America
    • 5.2.2. Latin America
    • 5.2.3. Europe
    • 5.2.4. East Asia
    • 5.2.5. South Asia and Oceania
    • 5.2.6. Middle East & Africa
  • 5.3. Market Attractiveness Analysis: Region

6. North America Electrophysiology Ablation Market Outlook

  • 6.1. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 6.1.1. By Country
    • 6.1.2. By Product
    • 6.1.3. By Application
    • 6.1.4. By End-User
  • 6.2. Current Market Size (US$ Mn) Analysis and Forecast by Country, 2025-2032
    • 6.2.1. U.S.
    • 6.2.2. Canada
  • 6.3. Current Market Size (US$ Mn) Analysis, by Product, 2025-2032
    • 6.3.1. Diagnostic Catheter
    • 6.3.2. Ablation Catheter
    • 6.3.3. Access Device
  • 6.4. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
    • 6.4.1. Supraventricular tachycardia (SVT) ablation
    • 6.4.2. Ventricular tachycardia (VT/VPC)
    • 6.4.3. Atrial fibrillation (AF)
    • 6.4.4. Atrial flutter
    • 6.4.5. Others
  • 6.5. Current Market Size (US$ Mn) Analysis and Forecast, By End-User, 2025-2032
    • 6.5.1. Hospital
    • 6.5.2. Ambulatory Surgical Centre
    • 6.5.3. Specialty Cardiac Centers
    • 6.5.4. Clinic
  • 6.6. Market Attractiveness Analysis

7. Europe Electrophysiology Ablation Market Outlook

  • 7.1. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 7.1.1. By Country
    • 7.1.2. By Product
    • 7.1.3. By Application
    • 7.1.4. By End-User
  • 7.2. Current Market Size (US$ Mn) Analysis and Forecast by Country, 2025-2032
    • 7.2.1. Germany
    • 7.2.2. France
    • 7.2.3. U.K.
    • 7.2.4. Italy
    • 7.2.5. Spain
    • 7.2.6. Russia
    • 7.2.7. Rest of Europe
  • 7.3. Current Market Size (US$ Mn) Analysis, by Product, 2025-2032
    • 7.3.1. Diagnostic Catheter
    • 7.3.2. Ablation Catheter
    • 7.3.3. Access Device
  • 7.4. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
    • 7.4.1. Supraventricular tachycardia (SVT) ablation
    • 7.4.2. Ventricular tachycardia (VT/VPC)
    • 7.4.3. Atrial fibrillation (AF)
    • 7.4.4. Atrial flutter
    • 7.4.5. Others
  • 7.5. Current Market Size (US$ Mn) Analysis and Forecast, By End-User, 2025-2032
    • 7.5.1. Hospital
    • 7.5.2. Ambulatory Surgical Centre
    • 7.5.3. Specialty Cardiac Centers
    • 7.5.4. Clinic
  • 7.6. Market Attractiveness Analysis

8. East Asia Electrophysiology Ablation Market Outlook

  • 8.1. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 8.1.1. By Country
    • 8.1.2. By Product
    • 8.1.3. By Application
    • 8.1.4. By End-User
  • 8.2. Current Market Size (US$ Mn) Analysis and Forecast by Country, 2025-2032
    • 8.2.1. China
    • 8.2.2. Japan
    • 8.2.3. South Korea
  • 8.3. Current Market Size (US$ Mn) Analysis, by Product, 2025-2032
    • 8.3.1. Diagnostic Catheter
    • 8.3.2. Ablation Catheter
    • 8.3.3. Access Device
  • 8.4. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
    • 8.4.1. Supraventricular tachycardia (SVT) ablation
    • 8.4.2. Ventricular tachycardia (VT/VPC)
    • 8.4.3. Atrial fibrillation (AF)
    • 8.4.4. Atrial flutter
    • 8.4.5. Others
  • 8.5. Current Market Size (US$ Mn) Analysis and Forecast, By End-User, 2025-2032
    • 8.5.1. Hospital
    • 8.5.2. Ambulatory Surgical Centre
    • 8.5.3. Specialty Cardiac Centers
    • 8.5.4. Clinic
  • 8.6. Market Attractiveness Analysis

9. South Asia & Oceania Electrophysiology Ablation Market Outlook

  • 9.1. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 9.1.1. By Country
    • 9.1.2. By Product
    • 9.1.3. By Application
    • 9.1.4. By End-User
  • 9.2. Current Market Size (US$ Mn) Analysis and Forecast by Country, 2025-2032
    • 9.2.1. India
    • 9.2.2. Indonesia
    • 9.2.3. Thailand
    • 9.2.4. Singapore
    • 9.2.5. ANZ
    • 9.2.6. Rest of South Asia & Oceania
  • 9.3. Current Market Size (US$ Mn) Analysis, by Product, 2025-2032
    • 9.3.1. Diagnostic Catheter
    • 9.3.2. Ablation Catheter
    • 9.3.3. Access Device
  • 9.4. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
    • 9.4.1. Supraventricular tachycardia (SVT) ablation
    • 9.4.2. Ventricular tachycardia (VT/VPC)
    • 9.4.3. Atrial fibrillation (AF)
    • 9.4.4. Atrial flutter
    • 9.4.5. Others
  • 9.5. Current Market Size (US$ Mn) Analysis and Forecast, By End-User, 2025-2032
    • 9.5.1. Hospital
    • 9.5.2. Ambulatory Surgical Centre
    • 9.5.3. Specialty Cardiac Centers
    • 9.5.4. Clinic
  • 9.6. Market Attractiveness Analysis

10. Latin America Electrophysiology Ablation Market Outlook

  • 10.1. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 10.1.1. By Country
    • 10.1.2. By Product
    • 10.1.3. By Application
    • 10.1.4. By End-User
  • 10.2. Current Market Size (US$ Mn) Analysis and Forecast by Country, 2025-2032
    • 10.2.1. Brazil
    • 10.2.2. Mexico
    • 10.2.3. Rest of Latin America
  • 10.3. Current Market Size (US$ Mn) Analysis, by Product, 2025-2032
    • 10.3.1. Diagnostic Catheter
    • 10.3.2. Ablation Catheter
    • 10.3.3. Access Device
  • 10.4. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
    • 10.4.1. Supraventricular tachycardia (SVT) ablation
    • 10.4.2. Ventricular tachycardia (VT/VPC)
    • 10.4.3. Atrial fibrillation (AF)
    • 10.4.4. Atrial flutter
    • 10.4.5. Others
  • 10.5. Current Market Size (US$ Mn) Analysis and Forecast, By End-User, 2025-2032
    • 10.5.1. Hospital
    • 10.5.2. Ambulatory Surgical Centre
    • 10.5.3. Specialty Cardiac Centers
    • 10.5.4. Clinic
  • 10.6. Market Attractiveness Analysis

11. Middle East & Africa Electrophysiology Ablation Market Outlook

  • 11.1. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 11.1.1. By Country
    • 11.1.2. By Product
    • 11.1.3. By Application
    • 11.1.4. By End-User
  • 11.2. Current Market Size (US$ Mn) Analysis and Forecast by Country, 2025-2032
    • 11.2.1. GCC Countries
    • 11.2.2. Egypt
    • 11.2.3. South Africa
    • 11.2.4. Northern Africa
    • 11.2.5. Rest of Middle East & Africa
  • 11.3. Current Market Size (US$ Mn) Analysis, by Product, 2025-2032
    • 11.3.1. Diagnostic Catheter
    • 11.3.2. Ablation Catheter
    • 11.3.3. Access Device
  • 11.4. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
    • 11.4.1. Supraventricular tachycardia (SVT) ablation
    • 11.4.2. Ventricular tachycardia (VT/VPC)
    • 11.4.3. Atrial fibrillation (AF)
    • 11.4.4. Atrial flutter
    • 11.4.5. Others
  • 11.5. Current Market Size (US$ Mn) Analysis and Forecast, By End-User, 2025-2032
    • 11.5.1. Hospital
    • 11.5.2. Ambulatory Surgical Centre
    • 11.5.3. Specialty Cardiac Centers
    • 11.5.4. Clinic
  • 11.6. Market Attractiveness Analysis

12. Competition Landscape

  • 12.1. Market Share Analysis, 2025
  • 12.2. Market Structure
    • 12.2.1. Competition Intensity Mapping by Market
    • 12.2.2. Competition Dashboard
  • 12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 12.3.1. Biosense Webster
      • 12.3.1.1. Overview
      • 12.3.1.2. Segments and Sources
      • 12.3.1.3. Key Financials
      • 12.3.1.4. Market Developments
      • 12.3.1.5. Market Strategy
    • 12.3.2. Abbott Laboratories
    • 12.3.3. MEDTRONIC PLC
    • 12.3.4. Boston Scientific Corporation
    • 12.3.5. CathRx Ltd
    • 12.3.6. Biotronik SE & Co. KG.
    • 12.3.7. Japan Lifeline Co
    • 12.3.8. ATRICURE, INC.
    • 12.3.9. Auris Health
    • 12.3.10. Biomerics.
    • 12.3.11. Others

13. Appendix

  • 13.1. Research Methodology
  • 13.2. Research Assumptions
  • 13.3. Acronyms and Abbreviations
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦